|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01343849 |
|
Date of registration:
|
27/04/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Blood Test for Breast Cancer Associated Auto Antibodies
|
|
Scientific title:
|
Blood Test for Breast Cancer Associated Auto Antibodies |
|
Date of first enrolment:
|
September 2011 |
|
Target sample size:
|
1000 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01343849 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Galit Yahalom, Ph.D. |
|
Address:
|
|
|
Telephone:
|
972-546-922422 |
|
Email:
|
galit@eventusdx.com |
|
Affiliation:
|
|
|
|
Name:
|
Tanir Allweis, MD |
|
Address:
|
|
|
Telephone:
|
972-8-9442295 |
|
Email:
|
taniral@clalit.org.il |
|
Affiliation:
|
|
|
|
Name:
|
Tanir Allweis, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kaplan Medical Center |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Female subjects 18 years or over.
- Subjects suspected of breast cancer. The clinical suspicion will include one of the
following: positive mammography, ultrasound (US), magnetic resonance imaging (MRI),
suspected physical exam. Final analysis will be done in relation to pathology only.
- Subjects scheduled biopsy/surgery
Exclusion Criteria:
- Female Subjects less than 18 years of age
- Previous or concurrent malignancies
- Autoimmune disorders diagnosed subjects
- Hematological malignancies
- Subjects under active chemotherapy treatment or chemotherapy in the past 6 months
- Steroid treatment in the past 3 months
- Subject undergoing immunosuppressive treatments
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Breast Cancer
|
|
Secondary ID(s)
|
|
EventusDx_breast_2011ver2
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|